d-alpha tocopherol has been researched along with Diabetic Angiopathies in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.13) | 18.7374 |
| 1990's | 16 (34.04) | 18.2507 |
| 2000's | 20 (42.55) | 29.6817 |
| 2010's | 10 (21.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; He, Y; Li, D; Meng, L; Wu, Z; Zhang, H; Zheng, C; Zheng, X | 1 |
| Albanes, D; Kataja-Tuomola, MK; Kontto, JP; Männistö, S; Virtamo, JR | 1 |
| Kharchenkova, NV; Volchegorskiĭ, IA | 1 |
| Carreras, M; Januel, C; Lagarde, M; Moulin, P; Véricel, E | 1 |
| Chan, AV; Devaraj, S; Jialal, I | 1 |
| Dalan, R; Liuh Ling, G | 1 |
| Bruckdorfer, KR; Lennon, L; Papacosta, O; Shaper, AG; Wannamethee, SG; Whincup, PH | 1 |
| Blankenberg, S; Chapman, MJ; Landmesser, U | 1 |
| Bauer, JA; Cazeau, RM; Hoffman, RP; Huang, H | 1 |
| Turan, B; Zeydanli, EN | 1 |
| Blum, S; Levy, AP; Levy, NS; Miller-Lotan, R; Vardi, M | 1 |
| Poolsup, N; Sinprasert, S; Suksomboon, N | 1 |
| Liu, D; Tang, JY; Yan, L | 1 |
| Goldenstein, H; Levy, AP; Levy, NS | 1 |
| Bae, JH; Kim, HS; Lee, IK | 1 |
| Fujii, S; Hosoi, M; Sato, T | 1 |
| Bosch, J; Dagenais, G; Gerstein, HC; Hoogwerf, B; Lonn, E; Mann, JF; Pogue, J; Yi, Q; Yusuf, S; Zinman, B | 1 |
| Hilgertová, J; Prázný, M; Skrha, J; Weiserová, H | 1 |
| Cheng, CH; Chung, WS; Leung, AW; Yue, KK | 1 |
| Avanzini, F; Nicolucci, A; Pellegrini, F; Roncaglioni, MC; Sacco, M; Tognoni, G | 1 |
| Blasetti, A; Chiarelli, F; Cipollone, F; Mezzetti, A; Sabatino, G; Santilli, F; Tumini, S; Verrotti, A | 1 |
| Gerstein, HC; Levy, AP; Lonn, E; McQueen, M; Miller-Lotan, R; Pogue, J; Ratner, R | 1 |
| Atkinson, AB; Bell, PM; Fee, JP; McCance, DR; McSorley, PT; Sheridan, B; Young, IS | 1 |
| Dagenais, GR; Gerstein, HC; Lonn, E; Mann, JF; McQueen, M; Pogue, J; Yusuf, S | 1 |
| Baccarin, L; Ceriello, A; Fedele, D; Lapolla, A; Laverda, B; Piarulli, F; Ragazzi, E; Reitano, R; Sartore, G | 1 |
| Seymen, AA; Tandogan, B; Tanriverdi, E; Tuncay, E; Turan, B; Ulusu, NN; Yaras, N | 1 |
| Blum, S; Levy, AP | 1 |
| Betteridge, DJ; McCarthy, S; Nourooz-Zadeh, J; Tajaddini-Sarmadi, J; Wolff, SP | 1 |
| Andert, SE; Griesmacher, A; Kindhauser, M; Knoebl, P; Pietschmann, P; Prager, R; Schernthaner, G; Schnack, C; Schreiner, W; Toma, C | 1 |
| Gerster, H | 1 |
| Amemiya, S; Asayama, K; Dobashi, K; Hayashibe, H; Kato, K; Nakane, T; Nakazawa, S; Uchida, N | 1 |
| Dorchy, H; Ndahimana, J; Vertongen, F | 1 |
| Bosch, J; Gerstein, HC; Pogue, J; Taylor, DW; Yusuf, S; Zinman, B | 1 |
| Barnett, AH; Baxter, MA; Jones, AF; Leguen, C; Maxwell, SR; Sandler, D; Thomason, H; Thorpe, GH | 1 |
| Bozkurt, O; Erdoğan, D; Karasu, C; Omeroğlu, S; Ozansoy, G | 1 |
| McCarty, MF | 1 |
| Bortolotti, N; Ceriello, A; Crescentini, A; Giacomello, R; Motz, E; Pirisi, M; Russo, A; Stel, G; Taboga, C; Tonutti, L | 1 |
| Oranje, WA; Rondas-Colbers, GJ; Swennen, GN; Wolffenbuttel, BH | 1 |
| Du, X; Rösen, P; Tschöpe, D | 1 |
| Chaya, S; Hamada, Y; Hara, T; Hotta, N; Kasuya, Y; Kato, K; Koh, N; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sasaki, H | 1 |
| Rösen, P; Toeller, M | 1 |
| Bursell, SE; King, GL | 1 |
| Devaraj, S; Jialal, I | 2 |
| Mancini, GB; Stewart, DJ | 1 |
| Inoguchi, T; Kunisaki, M; Nawata, H; Umeda, F; Watanabe, J | 1 |
| Schwarz, D | 1 |
10 review(s) available for d-alpha tocopherol and Diabetic Angiopathies
| Article | Year |
|---|---|
The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Topics: Animals; Antioxidants; Clinical Decision-Making; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Supplements; Genetic Association Studies; Genetic Predisposition to Disease; Haptoglobins; Humans; Oxidative Stress; Phenotype; Polymorphism, Genetic; Precision Medicine; Prognosis; Risk Factors; Vitamin E | 2018 |
The year in cardiology 2015: prevention.
Topics: Adrenocorticotropic Hormone; Antibodies, Monoclonal; Anticholesteremic Agents; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Diabetic Angiopathies; Disease Progression; Dyslipidemias; Global Health; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoprotein(a); PCSK9 Inhibitors; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Risk Assessment; Therapies, Investigational; Vitamin E | 2016 |
Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Supplements; Glycated Hemoglobin; Humans; Hyperglycemia; Randomized Controlled Trials as Topic; Vitamin E; Vitamin E Deficiency | 2011 |
Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.
Topics: Animals; Antioxidants; Diabetic Angiopathies; Genetic Predisposition to Disease; Haptoglobins; Heme; Hemoglobins; Humans; Iron; Oxidation-Reduction; Oxidative Stress; Phenotype; Polymorphism, Genetic; Vitamin E | 2012 |
[Lipid peroxide].
Topics: Biomarkers; Diabetes Mellitus; Diabetic Angiopathies; Humans; Isoprostanes; Lipid Peroxides; Vitamin E | 2002 |
Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
Topics: Antioxidants; Cardiovascular Diseases; Diabetic Angiopathies; Female; Haptoglobins; Humans; Male; Oxidative Stress; Pharmacogenetics; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Treatment Outcome; Vitamin E | 2007 |
Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis.
Topics: Antioxidants; Arteriosclerosis; Blood Platelets; Diabetic Angiopathies; Humans; Membrane Lipids; Phospholipids; Platelet Aggregation; Vitamin E | 1993 |
Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol?
Topics: Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Free Radicals; Humans; Reactive Oxygen Species; Vitamin E | 1998 |
Vitamin E in diabetes. Increased oxidative stress and its prevention as a strategy to prevent vascular complications?
Topics: Diabetes Mellitus; Diabetic Angiopathies; Humans; Oxidative Stress; Vitamin E | 1999 |
Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?
Topics: Animals; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hyperglycemia; Isoenzymes; Muscle, Smooth, Vascular; Protein Kinase C; Vitamin E | 1999 |
12 trial(s) available for d-alpha tocopherol and Diabetic Angiopathies
| Article | Year |
|---|---|
Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study.
Topics: Aged; alpha-Tocopherol; beta Carotene; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Double-Blind Method; Finland; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Smoking; Stroke; Survival Rate; Treatment Outcome; Vitamins | 2010 |
alpha-Tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients.
Topics: alpha-Tocopherol; Antioxidants; Arteriosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Supplements; Humans; Lipids; P-Selectin; Plasminogen Activator Inhibitor 1; Reference Values | 2002 |
Effect of Vitamins C and E on Endothelial Function in Type 1 Diabetes Mellitus.
Topics: Adolescent; Age Factors; Antioxidants; Ascorbic Acid; Biomarkers; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dietary Supplements; Drug Combinations; Endothelial Progenitor Cells; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Male; Oxidative Stress; Treatment Outcome; Vasodilation; Vitamin E | 2016 |
[Effect of compound danshen dripping pill on arterial intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus].
Topics: Adult; Aged; Aspirin; Blood Glucose; Carotid Intima-Media Thickness; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drugs, Chinese Herbal; Female; Humans; Insulin Resistance; Male; Middle Aged; Phenanthrolines; Phytotherapy; Salvia miltiorrhiza; Vitamin E | 2010 |
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Heart Diseases; Humans; Male; Myocardial Infarction; Placebos; Stroke; Survival Rate; Treatment Outcome; Vitamin E | 2002 |
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Topics: Aged; Aspirin; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Risk Factors; Safety; Smoking; Vitamin E | 2003 |
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy.
Topics: Adolescent; Adult; Antioxidants; Catalase; Cells, Cultured; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Fibroblasts; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Superoxide Dismutase; Vitamin E | 2004 |
Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial.
Topics: Adolescent; Adult; Antioxidants; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Humans; Insulin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pedigree; Risk Factors; Vitamin E | 2005 |
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Fasting; Female; Glycated Hemoglobin; Humans; Kidney Diseases; Male; Placebos; Ramipril; Reference Values; Risk Factors; Vitamin E | 2005 |
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Preven
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Factor Analysis, Statistical; Humans; Middle Aged; Placebos; Ramipril; Research Design; Risk Factors; Time Factors; Vitamin E | 1996 |
Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease?
Topics: Aged; Analysis of Variance; Arteriosclerosis; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Netherlands; Peripheral Vascular Diseases; Reference Values; Statistics, Nonparametric; Thiobarbituric Acid Reactive Substances; Vitamin E | 1998 |
Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?
Topics: Angiotensin-Converting Enzyme Inhibitors; Death; Diabetes Complications; Diabetic Angiopathies; Female; Heart Diseases; Humans; Male; Middle Aged; Ramipril; Vitamin E | 2001 |
25 other study(ies) available for d-alpha tocopherol and Diabetic Angiopathies
| Article | Year |
|---|---|
α-Tocopherol, especially α-tocopherol phosphate, exerts antiapoptotic and angiogenic effects on rat bone marrow-derived endothelial progenitor cells under high-glucose and hypoxia conditions.
Topics: alpha-Tocopherol; Angiogenic Proteins; Animals; Apoptosis; Apoptosis Regulatory Proteins; Bone Marrow Cells; Bone Marrow Transplantation; Cell Hypoxia; Cell Movement; Cells, Cultured; Diabetic Angiopathies; Endothelial Progenitor Cells; Glucose; Hindlimb; Ischemia; Male; Muscle, Skeletal; Neovascularization, Physiologic; Rats, Sprague-Dawley; Signal Transduction; Stem Cell Niche; Time Factors | 2018 |
[Content of lipid peroxidation products, alpha-tocopherol and ceruloplasmin in the blood of patients with vascular complications of insulin-dependent diabetes mellitus].
Topics: Adolescent; Adult; alpha-Tocopherol; Antioxidants; Ceruloplasmin; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Humans; Lipid Peroxidation; Male; Middle Aged | 2003 |
Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status.
Topics: alpha-Tocopherol; Antioxidants; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glutathione Peroxidase; Glycated Hemoglobin; Humans; Lipid Peroxidation; Lipoxygenase; Middle Aged; Platelet Activation; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Reference Values; Thromboxane B2; Triglycerides | 2004 |
Plasma vitamin C, but not vitamin E, is associated with reduced risk of heart failure in older men.
Topics: Aged; Ascorbic Acid; Diabetic Angiopathies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Assessment; Vitamin E | 2013 |
Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta.
Topics: Animals; Aorta, Thoracic; Blotting, Western; Cyclic AMP; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Fatty Acids, Omega-3; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Nitrites; Rats; Rats, Wistar; Vitamin E | 2009 |
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Haptoglobins; Humans; Phenotype; Vitamin E | 2010 |
Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia.
Topics: Adult; Arteriosclerosis; Brachial Artery; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Fats; Endothelium, Vascular; Glucose; Humans; Hyperglycemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Oxidative Stress; Postprandial Period; Risk Factors; Vasodilation; Vitamin E | 2002 |
Serum alpha-tocopherol and ascorbic acid concentrations in Type 1 and Type 2 diabetic patients with and without angiopathy.
Topics: Acetylglucosamine; Adolescent; Adult; Antioxidants; Ascorbic Acid; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Lipids; Male; Malondialdehyde; Oxidative Stress; Serum Albumin; Triglycerides; Vitamin E | 2003 |
Redox changes precede the occurrence of oxidative stress in eyes and aorta, but not in kidneys of diabetic rats.
Topics: Animals; Antioxidants; Aorta, Thoracic; Blood Glucose; Blood Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Eye; Glutathione; Hemoglobins; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vitamin E | 2003 |
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Topics: Alleles; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Haptoglobins; Humans; Phenotype; Vitamin E | 2004 |
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease.
Topics: Aged; Antioxidants; Arterial Occlusive Diseases; Blood Flow Velocity; Body Mass Index; Brachial Artery; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Reference Values; Vitamin E | 2007 |
Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drug Combinations; Fatty Acids, Omega-3; Female; Heart Ventricles; Male; Models, Biological; Rats; Rats, Wistar; Sex Characteristics; Streptozocin; Ventricular Dysfunction, Left; Vitamin E | 2007 |
Elevated levels of authentic plasma hydroperoxides in NIDDM.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fatty Acids, Nonesterified; Female; Glycated Hemoglobin; Humans; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Reference Values; Thiobarbituric Acid Reactive Substances; Triglycerides; Vitamin E | 1995 |
Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus.
Topics: Adult; Aged; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Lipid Peroxidation; Male; Middle Aged; Thiobarbituric Acid Reactive Substances; Uric Acid; Vitamin E | 1995 |
Antioxidants in the serum of children with insulin-dependent diabetes mellitus.
Topics: Adolescent; Antioxidants; Ascorbic Acid; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Free Radical Scavengers; Free Radicals; Humans; Lipid Peroxidation; Male; Stress, Physiological; Uric Acid; Vitamin E | 1993 |
Erythrocyte and plasma antioxidant activity and subclinical complications in young diabetic patients.
Topics: Adolescent; Antioxidants; Ascorbic Acid; Biomarkers; C-Peptide; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Erythrocytes; Humans; Insulin; Insulin Secretion; Vitamin E | 1996 |
Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus.
Topics: Adult; Antioxidants; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Free Radical Scavengers; Free Radicals; Humans; Male; Middle Aged; Sulfhydryl Compounds; Uric Acid; Vitamin E | 1997 |
Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group.
Topics: Animals; Antioxidants; Aorta; Aortic Diseases; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypolipidemic Agents; Lipid Peroxidation; Male; Nitroprusside; Random Allocation; Rats; Triglycerides; Vasodilation; Vasodilator Agents; Vitamin E | 1997 |
Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications.
Topics: Complementary Therapies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diet, Fat-Restricted; Dietary Fiber; Exercise; Humans; Insulin Resistance; Iron Chelating Agents; Magnesium; Models, Biological; Picolinic Acids; Risk Factors; Taurine; Vitamin E; Weight Loss | 1997 |
Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Fragments; Predictive Value of Tests; Protein Precursors; Prothrombin; Reference Values; Regression Analysis; Risk Factors; Thrombosis; Uric Acid; Vitamin A; Vitamin E | 1997 |
Effect of vitamin E and allylamine on the proliferation of cultured aortic smooth muscle cells from streptozotocin-induced diabetic rats.
Topics: Allylamine; Animals; Antioxidants; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA; Free Radical Scavengers; Male; Malondialdehyde; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Thymidine; Vitamin E | 1999 |
Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.
Topics: Aged; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Diabetic Angiopathies; E-Selectin; Female; Glycosylation; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Lipoproteins, LDL; Male; Microcirculation; Middle Aged; Monocytes; Oxidation-Reduction; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vitamin E | 2000 |
Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.
Topics: Antioxidants; Arteriosclerosis; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Interleukin-6; Monocytes; Vitamin E | 2000 |
Effects of vitamin E administration on platelet function in diabetes mellitus.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Blood Glucose; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Thromboxane B2; Time Factors; Vitamin E | 1990 |
[Medical therapy of obliterating arteriopathies].
Topics: Arteriosclerosis Obliterans; Diabetic Angiopathies; Gangrene; Humans; Inositol; Niacinamide; Pyridoxine; Thromboangiitis Obliterans; Vascular Diseases; Vitamin E | 1969 |